Covetrus Announces Financial Results for First Quarter of 2019

    NEXT STORY
    BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC.
    PREV STORY
    “Global Dermatological Drugs Market Set to Grow To $36bn by 2024”, according to Visiongain
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Griffin-American Healthcare REIT IV Enters Agreement to Acquire Mint Hill Medical Office Building Near Charlotte

    CHARLOTTE, N.C., Oct. 06, 2016 (GLOBE NEWSWIRE) -- American Healthcare Investors and Griffin Capital ...

    author_avatar
    NASDAQ Market News

    Orbus Therapeutics Announces ASCO Study Design Presentation of Pivotal Clinical Trial in Patients with Late-Stage Brain Cancer

    PALO ALTO, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- Orbus Therapeutics Inc., a private, ...

    author_avatar
    NASDAQ Market News

    Intellia Therapeutics Names Fred Cohen, M.D., to Board of Directors

    author_avatar
    NASDAQ Market News